<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Psychiatry: Neuropathology Topic Collection</title>
    <link>http://archpsyc.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Mon, 01 Apr 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Wed, 03 Apr 2013 15:46:12 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archpsyc.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archpsyc.jamanetwork.com</webMaster>
    <item>
      <title>Antidepressants Normalize the Default Mode Network in Patients With Dysthymia Antidepressants and the Default Mode Network </title>
      <link>http://archpsyc.jamanetwork.com/article.aspx?articleID=1568957</link>
      <pubDate>Mon, 01 Apr 2013 00:00:00 GMT</pubDate>
      <author>Posner J, Hellerstein DJ, Gat I, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;The default mode network (DMN) is a collection of brain regions that reliably deactivate during goal-directed behaviors and is more active during a baseline, or so-called resting, condition. Coherence of neural activity, or functional connectivity, within the brain's DMN is increased in major depressive disorder relative to healthy control (HC) subjects; however, whether similar abnormalities are present in persons with dysthymic disorder (DD) is unknown. Moreover, the effect of antidepressant medications on DMN connectivity in patients with DD is also unknown.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To use resting-state functional-connectivity magnetic resonance imaging (MRI) to study (1) the functional connectivity of the DMN in subjects with DD vs HC participants and (2) the effects of antidepressant therapy on DMN connectivity.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;After collecting baseline MRI scans from subjects with DD and HC participants, we enrolled the participants with DD into a 10-week prospective, double-blind, placebo-controlled trial of duloxetine and collected MRI scans again at the conclusion of the study. Enrollment occurred between 2007 and 2011.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;University research institute.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;Volunteer sample of 41 subjects with DD and 25 HC participants aged 18 to 53 years. Control subjects were group matched to patients with DD by age and sex.&lt;div class="boxTitle"&gt;Main Outcome Measures&lt;/div&gt;We used resting-state functional-connectivity MRI to measure the functional connectivity of the brain's DMN in persons with DD compared with HC subjects, and we examined the effects of treatment with duloxetine vs placebo on DMN connectivity.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Of the 41 subjects with DD, 32 completed the clinical trial and MRI scans, along with the 25 HC participants. At baseline, we found that the coherence of neural activity within the brain's DMN was greater in persons with DD compared with HC subjects. Following a 10-week clinical trial, we found that treatment with duloxetine, but not placebo, normalized DMN connectivity.&lt;div class="boxTitle"&gt;Conclusions and Relevance&lt;/div&gt;The baseline imaging findings are consistent with those found in patients with major depressive disorder and suggest that increased connectivity within the DMN may be important in the pathophysiology of both acute and chronic manifestations of depressive illness. The normalization of DMN connectivity following antidepressant treatment suggests an important causal pathway through which antidepressants may reduce depression.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">70</prism:volume>
      <prism:number xmlns:prism="prism">4</prism:number>
      <prism:startingPage xmlns:prism="prism">373</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">382</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamapsychiatry.2013.455</prism:doi>
      <guid>http://archpsyc.jamanetwork.com/article.aspx?articleID=1568957</guid>
    </item>
    <item>
      <title> FKBP5  and Attention Bias for Threat Associations With Hippocampal Function and Shape   FKBP5  and Attention Bias for Threat </title>
      <link>http://archpsyc.jamanetwork.com/article.aspx?articleID=1570379</link>
      <pubDate>Mon, 01 Apr 2013 00:00:00 GMT</pubDate>
      <author>Fani N, Gutman D, Tone EB, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;The FKBP5 gene product regulates glucocorticoid receptor (GR) sensitivity and hypothalamic-pituitary-adrenal axis functioning and has been associated with many stress-related psychiatric disorders. The study of intermediate phenotypes, such as emotion-processing biases and their neural substrates, provides a way to clarify the mechanisms by which FKBP5 dysregulation mediates risk for psychiatric disorders.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To examine whether allelic variations for a putatively functional single-nucleotide polymorphism associated with FKBP5 gene regulation (rs1360780) would relate differentially to attention bias for threat. this was measured through behavioral response on a dot probe task and hippocampal activation during task performance. Morphologic substrates of differential hippocampal response were also measured.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Cross-sectional study conducted from 2010 to 2012 examining associations between genotype, behavioral response, and neural response (using functional magnetic resonance imaging [fMRI]) on the dot probe; voxel-based morphometry and global and local shape analyses were used to measure structural differences in hippocampi between genotype groups.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;Participants were recruited from primary care clinics of a publicly funded hospital in Atlanta, Georgia.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;An African American cohort of adults (N = 103) was separated into 2 groups by genotype: one genotype group included carriers of the rs1360780 T allele, which has been associated with increased risk for posttraumatic stress disorder and affective disorders; the other group did not carry this allele. Behavioral data included both sexes (N = 103); the MRI cohort (n = 36) included only women.&lt;div class="boxTitle"&gt;Main Outcome Measures&lt;/div&gt;Behavioral and fMRI (blood oxygen level–dependent) response, voxel-based morphometry, and shape analyses.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Carriers of the rs1360780 T allele showed an attention bias toward threat compared with individuals without this allele (F&lt;sub&gt;1,90&lt;/sub&gt; = 5.19, P = .02). Carriers of this allele demonstrated corresponding increases in hippocampal activation and differences in morphology; global and local shape analyses revealed alterations in hippocampal shape for TT/TC compared with CC genotype groups.&lt;div class="boxTitle"&gt;Conclusion&lt;/div&gt;Genetic variants of FKBP5 may be associated with risk for stress-related psychiatric disorders via differential effects on hippocampal structure and function, resulting in altered attention response to perceived threat.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">70</prism:volume>
      <prism:number xmlns:prism="prism">4</prism:number>
      <prism:startingPage xmlns:prism="prism">392</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">400</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/2013.jamapsychiatry.210</prism:doi>
      <guid>http://archpsyc.jamanetwork.com/article.aspx?articleID=1570379</guid>
    </item>
  </channel>
</rss>